Severance Hospital said it recently marked a milestone of 500 liver cancer radioembolization procedures. Radioembolization for liver cancer, a minimally invasive treatment, involves the insertion of a catheter into the femoral artery of the leg, guiding it to the hepatic artery, and injecting micros
Seoul National University Bundang Hospital (SNUBH) has spearheaded the launch of a network aimed at timely treatment of severe and emergency cardiocerebrovascular diseases, such as stroke and myocardial infarction, within Gyeonggi Province.This initiative, part of the Ministry of Health and Welfare'
More than a month has passed since Enhertu (trastuzumab deruxtecan), a new breast cancer drug provided by Daiichi Sankyo Korea and AstraZeneca Korea, passed the Drug Reimbursement Evaluation Committee under the Health Insurance Review and Assessment Service (HIRA).However, news on its reimbursement
Bridge Biotherapeutics has reported a significant downturn in its financial performance for the year 2023.The company's annual revenue plummeted to 100 million won ($74,878), marking a drastic 96.7 percent decrease compared to the previous year.This downturn is attributed to the absence of additiona
Professor Park Yeong-min of the Department of Integrative Biological Sciences and Industry at Sejong University has been appointed the second CEO of the Korea Drug Development Fund (KDDF).The KDDF said Monday that CEO Park began his term with an inauguration ceremony with the KDDF staff.Park's term
Seoul National University Bundang Hospital (SNUBH) said Tuesday that its research team has developed “ECG Buddy,” an artificial intelligence (AI) application for emergency disease prediction that analyzes electrocardiogram (ECG) images to assess myocardial infarction and arrhythmia.The research team
Forty medical schools nationwide have requested to enroll an additional 3,401 students for the 2025 academic year, according to government officials on Tuesday.If the government accepts such requests, the medical school enrollment quota will more than double the current 3,058.The Ministry of Health
In a recent statement titled "Weight Management and CGM," the Korean Society for the Study of Obesity (KSSO) has voiced concerns over the unverified use of continuous glucose monitoring (CGM) devices for weight loss in individuals without diabetes.Such concerns come amid companies like Dr.Diary intr
The Korean medical device sector showcased its latest technologies and research achievements at the European Congress of Radiology 2024 (ECR 2024), held from Feb. 28 to last Suday in Vienna, Austria. ECR is recognized as one of the world's largest conferences in the field of radiology, alongside the
Cosmetic device maker ilooda said Monday that it had signed a settlement agreement with Serendia LLC to resolve a U.S. International Trade Commission (ITC) investigation.In March 2023, Serendia filed a complaint with the ITC, alleging ilooda’s infringement on its "invasive RF" patent.Invasive RF is
Binex, a Kosdaq-listed biopharmaceutical CDMO, has been subjected to a two-month suspension of sales operations for Bimo 5mg (ingredient: minoxidil), a hair loss treatment, for failing to submit necessary documents for the 2023 drug equivalence reevaluation.The product in question will not be availa
MSD's 15-valent pneumococcal conjugate vaccine (PCV), Vaxneuvance, will be used in Korea in earnest next month as part of the government’s pediatric national immunization program (NIP).MSD Korea said it had secured sufficient batches of Vaxneuvance to prepare for its full-scale launch.Vaxneuvance is
ProEn Therapeutics, which develops antibody-drug conjugates (ADCs), said Monday that it has completed attracting a strategic investment from Kolmar Korea Holdings.The investment amount was not disclosed per the agreement between the two companies.The investment is part of an open innovation program
The government has begun to operate an emergency operation center (EOC) to support the transfer of emergency patients among hospitals in response to trainee physicians’ massive walkouts.To deal with doctors’ collective action, the Ministry of Health and Welfare said it began operating the EOC, a tem
The Korean medical community is facing an unprecedented crisis as tensions escalate between the government and healthcare professionals over the proposed increase in medical school admissions by 2,000 in 2025.The dispute has broadened from trainee doctors to encompass the entire medical sector, with
GSK Korea's inhalation-type triple combination asthma medicines Trelegy 100 Ellipta (fluticasone furoate/umeclidinium/vilanterol) and Trelegy200 Ellipta will get health insurance benefits starting this month.According to a notice by the Ministry of Health and Welfare and the Health Insurance Review
The government's survey, demanding adjustments to the medical school enrollment quotas of 40 universities with medical programs, is scheduled to conclude at midnight on Thursday.Against this backdrop, university presidents and medical professors at some universities clash with each other over this c
i-SENS, a Kosdaq-listed biotech company, said it received product approval for CareSens Air, its continuous glucose monitoring (CGM) device, from the European Conformité Européenne (CE) Medical Device Regulation (MDR) last Thursday.The CareSens Air CGM system offers a non-invasive solution for diabe
Coreline Soft's AVIEW Aorta has been recognized as an innovative medical device with insurance benefits, broadening its application in emergency medicine and establishing itself as a new source of revenue.On Monday, the medical AI company announced that AVIEW Aorta, a class 3 cardiovascular image de
Samjin Pharmaceutical announced a strategic investment of 1 billion won ($751,371) in Neurophet, a company specializing in AI solutions for brain disorder imaging, to fight dementia and stroke.Under the accord, the two companies seek to leverage Samjin’s extensive research resources, infrastructure,